The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for SQ Wang


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents.EBI
Zhengzhou University
The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases.EBI
Children's Hospital Affiliated to Zhengzhou University
Discovery of 2-Aryl-4-aminoquinazolin-Based LSD1 Inhibitors to Activate Immune Response in Gastric Cancer.EBI
Zhengzhou University
Oxazolidinone: A promising scaffold for the development of antibacterial drugs.EBI
Children's Hospital Affiliated to Zhengzhou University
Application and synthesis of thiazole ring in clinically approved drugs.EBI
Zhengzhou University
FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application.EBI
Zhengzhou University
Discovery of the Triazolo[1,5-EBI
Zhengzhou University
Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-EBI
Zhengzhou University
Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR).EBI
Zhengzhou University